Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Protalix BioTherapeutics (PLX) Inventory Average (2016 - 2025)

Protalix BioTherapeutics (PLX) has 14 years of Inventory Average data on record, last reported at $21.2 million in Q3 2025.

  • For Q3 2025, Inventory Average rose 11.78% year-over-year to $21.2 million; the TTM value through Sep 2025 reached $21.2 million, up 11.78%, while the annual FY2024 figure was $20.1 million, 12.38% up from the prior year.
  • Inventory Average reached $21.2 million in Q3 2025 per PLX's latest filing, up from $20.3 million in the prior quarter.
  • Across five years, Inventory Average topped out at $21.5 million in Q2 2024 and bottomed at $13.5 million in Q1 2021.
  • Average Inventory Average over 5 years is $18.1 million, with a median of $19.0 million recorded in 2024.
  • Peak YoY movement for Inventory Average: skyrocketed 53.02% in 2021, then dropped 8.01% in 2024.
  • A 5-year view of Inventory Average shows it stood at $16.3 million in 2021, then dropped by 4.03% to $15.7 million in 2022, then grew by 29.53% to $20.3 million in 2023, then decreased by 5.38% to $19.2 million in 2024, then increased by 10.26% to $21.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory Average were $21.2 million in Q3 2025, $20.3 million in Q2 2025, and $20.4 million in Q1 2025.